Anixa Biosciences
ANIX
62 hedge funds and large institutions have $15M invested in Anixa Biosciences in 2026 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 7 closing their positions.
1,640% more call options, than puts
Call options by funds: $261K | Put options by funds: $15K
129% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 7
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
14% more capital invested
Capital invested by funds: $13.1M → $15M (+$1.82M)
3% more funds holding
Funds holding: 60 → 62 (+2)
0.52% more ownership
Funds ownership: 15.18% → 15.7% (+0.52%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$431K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$94K |
| 3 |
MWM
Modern Wealth Management
Lenexa,
Kansas
|
+$89K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$88.7K |
| 5 |
LPL Financial
San Diego,
California
|
+$85K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$277K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$44.6K |
| 3 |
Two Sigma Investments
New York
|
-$37.4K |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$36.2K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$33K |
ANIX Hedge Fund Activity: Q2 2026 in Review
62 of the 8,286 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q2 2026, worth a combined $15M — up 14% from $13.1M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ANIX positions and 7 closed out — a net gain of 3 holders — while 16 added to existing stakes and 7 trimmed.
The largest buyer was Marshall Wace, adding an estimated $431K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $277K sold.
- 62 institutional investors held Anixa Biosciences (ANIX) as of Q2 2026, up from 60 in Q1 2026.
- Funds reported $15M of Anixa Biosciences stock for Q2 2026, up 14% quarter-over-quarter.
- 10 funds opened new Anixa Biosciences positions in Q2 2026 and 7 closed out, a net change of +3 holders.
- The largest Anixa Biosciences buyer in Q2 2026 was Marshall Wace, an estimated $431K added.
- The largest Anixa Biosciences seller in Q2 2026 was Susquehanna International Group, an estimated $277K sold.
Based on aggregated 13F filings for Q2 2026.